meerecompany (CEO Joon Koo Kim) has announced that Severance Hospital has started performing robotic surgery with the surgical robot Revo-i and recently completed the first successful hepatopancreatic biliary surgery.
On the 14th April, Professor Chang Moo Kang, Division of Hepatobiliary and Pancreatic Surgery at Severance Hospital successfully completed a robotic whipple surgery (pancreaticoduodenectomy) using Revo-i. This was the first surgery performed in the Division of Hepatobiliary and Pancreatic Surgery after the recent introduction of Revo-i in Severance Hospital. The hospital has experience in conducting 2 clinical trials of Revo-i. The surgery was performed for a patient who was diagnosed with pancreatic cancer and had also received anticancer treatment before the surgery. The patient is recovering in a stable condition.
Whipple surgery is known to be very difficult as it involves sectioning the head part of the pancreas, duodenum, a part of the small intestine, the lower part of the stomach, the common bile duct, and the bladder. The surgery then involves connecting the small intestine to the remaining pancreas, bile duct, and the upper part of the stomach.
“Based on the clinical trials and research conducted so far, the domestically developed K-surgical robot now performs as well as foreign machines. The surgery was done very smoothly, and now we are committed to the patient’s recovery. We will continue our efforts to give help and hope to patients who need minimally invasive surgeries with the domestic surgical robot,” said Professor Kang, who performed this surgery.
Professor Chang Moo Kang, Division of Hepatobiliary and Pancreatic Surgery, Severance Hospital is a renowned expert of minimally invasive surgery in the field of hepatopancreatic biliary surgery. He has published 71 papers related to pancreatectomy since 2011 and was selected by Expertscape, a US medical academic research evaluation institution, as 0.1% out of 22,699 experts around the globe.
“Revo-i provides the benefits of a high-resolution 3D stereoscopic image, wide view, and multi-joint devices to support fine and delicate motions so that medical professionals can perform sophisticated and safe robotic surgery. Starting from the high-difficulty whipple surgery performed this time, we are expecting that it will demonstrate its safety and efficacy in more surgeries,” said Joon Koo Kim, CEO of meerecompany regarding the aforesaid achievement.
Revo-i, a surgical robot that meerecompany developed and successfully commercialized for the first time in the country, was supplied to Severance Hospital in March. With such supply to Severance Hospital, which possesses world-class robotic surgery experience and is considered one of the domestic top medical institutions, it is expected that Revo-i clinical references will grow richer in more indications, including high-difficulty robotic surgery.